Safe arrest

How Diazon’s antimitotic sidesteps side effects

Although antimitotics remain a staple in cancer therapy for their ability to kill rapidly dividing cells, their high toxicity in normal, non-dividing cells presents a large side effect burden to patients. Diazon Pharmaceuticals Inc. is developing a compound that targets microtubules by a different mechanism than any of the approved antimitotics, resulting in a wider safety margin.

Microtubules are composed of tubulin dimers and play multiple

Read the full 652 word article

How to gain access

Continue reading with a
two-week free trial.